Abstract
Objectives
To investigate equilibrium contrast-enhanced CT (EQ-CT) measurement of extracellular volume fraction (ECV) in patients with systemic amyloid light-chain (AL) amyloidosis, testing the hypothesis that ECV becomes elevated in the liver and spleen and ECV correlates with other estimates of organ amyloid burden.
Methods
26 patients with AL amyloidosis underwent EQ-CT, and ECV was measured in the liver and spleen. Patients also underwent serum amyloid P (SAP) component scintigraphy with grading of liver and spleen involvement. Mann–Whitney U test was used to test for a difference between patients with amyloid deposition (SAP grade 1–3) and those without (SAP grade 0). Variation in ECV across SAP grades was assessed using the Kruskal–Wallis test and association between ECV and SAP grades with Spearman correlation.
Results
Mean ECV in the spleen and liver was significantly greater (p < 0.0005) in amyloidotic organs (SAP grade 1–3) [spleen, liver: 0.430, 0.375] compared with healthy tissues [spleen, liver: 0.304, 0.269]. ECV increased with increasing amyloid burden, showing positive correlation with SAP grade in both the liver (r = 0.758) and spleen (r = 0.867).
Conclusion
In patients with systemic AL amyloidosis, EQ-CT can demonstrate increased spleen and liver ECV, which is associated with amyloid disease burden.
Similar content being viewed by others
Abbreviations
- AL amyloidosis:
-
Systemic amyloid light-chain amyloidosis
- EQ-CT:
-
Equilibrium contrast-enhanced computed tomography
- EQ-MRI:
-
Equilibrium contrast-enhanced magnetic resonance imaging
- EQ-CMR:
-
Equilibrium contrast cardiac MRI
- ECV:
-
Extracellular volume fraction
- SAP:
-
Serum amyloid P
References
Gillmore JD, Hawkins PN (2013) Pathophysiology and treatment of systemic amyloidosis. Nat Rev Nephrol 9(10):574–586
Sattianavagam PT, Hawkins PN, Gillmore JD (2009) Systemic amyloidosis and the gastrointestinal tract. Nat Rev Gastroenterol Hepatol 6(10):608–617
Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins P (1998) The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients. Gut 42(5):727–734
Monzawa S, Tsukamoto T, Omata K, et al. (2002) A Case with primary amyloidosis of the liver and spleen: radiologic findings. Eur J Radiol 41(3):237–241
Sachchithanantham S, Wechalekar AD (2013) Imaging in systemic amyloidosis. Br Med Bull 107(1):41–56
Georgiades CS, Neyman EG, Barish MA, Fishman EK (2004) Amyloidosis: review and CT manifestations. Radiographics 24(2):405–416
Bandula S, White SJ, Flett AS, et al. (2013) Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. Radiology 269(2):396–403
Banypersad SM, Sado DM, Flett AS, et al. (2013) Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circulation 6(1):34–39
Treibel TA, Bandula S, Fontana M, et al. (2015) Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J Cardiovasc Comput Tomogr 9(6):585–592
Bandula S, Punwani S, Rosenberg WM, et al. (2015) Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling. Radiology 275(1):136–143
Varenika V, Fu Y, Maher JJ, et al. (2013) Hepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT. Radiology 266(1):151–158
Zissen MH, Wang ZJ, Yee J, et al. (2013) Contrast-enhanced CT quantification of hepatic fractional extraceullar space: correlation with diffuse liver disease severity. Am J Roentgenol 201(6):1204–1210
Yoon JH, Lee JM, Klotz E, et al. (2015) Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for hepatic fibrosis grading. Invest Radiol 50(4):290–296
Bandula S, Banypersad SM, Sado DM, et al. (2013) Measurement of tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging. Radiology 268(3):858–864
Hawkins PN, Lavender JP, Pepys MB (1990) Evaluation of systemic amyloidosis by scintigraphy with 123 I-labelled serum amyloid P component. N Engl J Med 25(7):709–713
Rydh A, Suhr O, Hietala SO, et al. (1998) Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med 25(7):2197–2215
Hazenburg BP, van Rijswijk MH, Piers DA, et al. (2006) Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 119(4):355
White SK, Sado DM, Fontana M, et al. (2013) T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging 6(9):955–962
Chen B, Marin D, Richard S, et al. (2013) Precision of iodine quantification in hepatic CT: effects of iterative reconstruction with various imaging parameters. Am J Roentgenol. 200(5):W475–W482
Shuman WP, Green DE, Busey JM, et al. (2013) Model-based Iterative reconstruction versus adaptive statistical iterative reconstruction and filtered back projection in liver 64-MDCT: focal lesion detection, lesion conspicuity and image noise. AM J Roentgenol 200(5):1071–1076
Kase KR, Strom DJ, Thomadsen BR, Suleiman OH, Quinn DM, Miller KL (2009) National Council on Radiation Protection Report no. 160, Ionizing Radiation Exposure of the Population of the United States. National Council on Radiation Protection and Measurements
Acknowledgements
We gratefully acknowledge the contributions of CT radiographers Elaine Atkins and Preeya Patel at University College London Hospital, David Edwards at the Royal Free Hospital, and Toshiba’s CT specialists Mark Condron and Tristan Lawton. TA Treibel and S Bandula are supported by Doctoral Research Fellowships from NIHR, UK (NIHR-DRF-2013-06-102/NIHR-DRF-2011-04-008). S Taylor is an NIHR senior investigator. The majority of this work was undertaken at University College London Hospital and University College London, which receive a proportion of funding from the NIHR Biomedical Research Centre funding scheme.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study has received funding from the National Amyloid Centre to cover scanning costs.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Institutional Review Board approval was obtained. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Yeung, J., Sivarajan, S., Treibel, T.A. et al. Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CT. Abdom Radiol 42, 2646–2651 (2017). https://doi.org/10.1007/s00261-017-1194-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-017-1194-4